Tescilar 22.5mg Injection

Tescilar 22.5mg Injection contains the active ingredient Leuprolide acetate. It is a gonadotropin-releasing hormone (GnRH) agonist. Tescilar 22.5mg Injection is used to treat prostate cancer in men, hormone-responsive breast cancer, endometriosis (tissue that normally lines the interior of the uterus grows outside of it) and uterine fibroids (noncancerous growths of the uterus) in women. This medicine is also used to treat premature puberty (central precocious puberty); due to certain hormonal releases, a child's body begins to change into an adult at an early age. Do not take this if you are allergic to Leuprolide acetate or any other ingredients, including Goserelin and Triptorelin, of the medicine and products relating to gonadotropin-releasing hormone (GnRH). During treatment, existing symptoms may worsen due to initial sex steroid increase in the body. This will subside after continual use of the medicine. Speak to your physician for further concerns. This medicine is not recommended in pregnant and breastfeeding women and patients with abnormal vaginal bleeding. It is not recommended if you experience abnormal vaginal bleeding. It is not recommended if you experience seizures or mood disorders. Men who experience urinary blockage or who have undergone testicular excision should inform their physician. Bone density measurement at regular intervals is advised. If you are a woman of childbearing age, use non-hormonal contraceptives while taking Tescilar 22.5mg Injection. Tell your doctor if you feel pressure on the spinal cord and experience urinary disorders and haematuria (blood in the urine). Inform your doctor about any underlying medical disorders you may have before beginning therapy, such as diabetes, seizures, heart problems including chest pain, irregular heartbeats, depression, or increased risk of osteoporosis (thinning of the bones). Inform your healthcare professional about all the medicines you are taking, including prescription, over-the-counter, herbal and vitamin supplements, before starting therapy.

Prostate cancer Hormone-responsive breast cancer in perimenopausal (around menopause) women Endometriosis (a painful illness in which the tissue that normally lines the inside of the uterus grows outside of your uterus) Central precocious puberty in children under 10 years (a child’s body begins to change into an adult too soon caused by a release of certain hormones)

Tescilar 22.5mg Injection is usually administered in the arm, thigh or abdomen. If this injection is recommended for you, it will be given by a healthcare professional. Do not self-administer. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.

Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. Serious: Severe rash, itching Osteoporosis Hyperglycemia Mood changes Cardiovascular risks Common: Injection site reactions Loss of appetite Swelling in the ankle or hand Difficulty sleeping, headache Mood swings, depression Weight changes Nausea, vomiting Vaginal dryness, bleeding Loss of interest in sexual intercourse Hot flushes Bone pain, muscle weakness Breast tenderness

During the treatment of breast cancer, regular checkups every three months during the treatment with the combination of an aromatase inhibitor. Do not receive this injection if you experience any abnormal vaginal bleeding. Consult your doctor immediately if you or your child is suffering from a headache, even after treating it with painkillers, vision problems, buzzing, or ringing in the ear. If you have diabetes, ask your doctor to monitor your glucose and blood sugar levels regularly. Before starting, inform your doctor if you are still menstruating. If you suffer weakness or dizziness as a side effect of Tescilar 22.5mg Injection, stay away from hard lifting and taxing activities. If you notice a loss of appetite, don't worry if it lasts for a day or two, but if it persists or if you are losing weight, inform your nurse or dietitian for guidance. They may recommend supplements, dietary changes, or adjustments to eating habits to address these issues. This treatment can affect fertility in men and women. If you are worried about this, it is important to talk with your doctor before you start this treatment.